Regent Pacific Group Limited (HKG:0575)
0.8500
-0.0400 (-4.49%)
Aug 27, 2026, 4:08 PM HKT
Regent Pacific Group Market Cap
Regent Pacific Group has a market cap or net worth of 259.72 million as of August 27, 2026. Its market cap has increased by 3.49% in one year.
Market Cap
259.72M
Enterprise Value
315.67M
Revenue
42.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.85
ChartMarket Cap Chart
Since March 10, 2016, Regent Pacific Group's market cap has decreased from 13.03B to 259.72M, a decrease of -98.01%. That is a compound annual growth rate of -31.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 259.72M | -16.82% |
| Dec 31, 2025 | 312.24M | 274.48% |
| Dec 31, 2024 | 83.38M | -41.12% |
| Dec 29, 2023 | 141.60M | -25.33% |
| Dec 30, 2022 | 189.63M | -48.68% |
| Dec 31, 2021 | 369.51M | -17.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fusen Pharmaceutical Company | 669.07M |
| Lee's Pharmaceutical Holdings | 668.33M |
| Zhongzhi Pharmaceutical Holdings | 591.57M |
| China NT Pharma Group Company | 341.64M |
| Wai Yuen Tong Medicine Holdings | 323.17M |
| Tianda Pharmaceuticals | 240.80M |
| Extrawell Pharmaceutical Holdings | 226.20M |
| Shenzhen Neptunus Interlong Bio-technique Company | 182.90M |